NCT01449578View on ClinicalTrials.gov

Dexpramipexole SAD/MAD Study

PHASE1CompletedINTERVENTIONAL

Enrollment

63

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG

Dexpramipexole

Oral Tablet at varying doses

DRUG

Dexpramipexole Placebo

Oral tablet at varying doses

Trial Locations (1)

Unknown

Research Site, Overland Park

Sponsors

Lead Sponsor

Knopp Biosciences

All Listed Sponsors

lead

Knopp Biosciences

INDUSTRY

NCT01449578 - Dexpramipexole SAD/MAD Study | Biotech Hunter | Biotech Hunter